Kaitlind C Howard

A comprehensive overview of the medicinal chemistry of antifungal drugs: perspectives and promise.

D. Watt, S. Garneau‐Tsodikova, Emily K Dennis, 2020, Chemical Society reviews.

Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.

S. Garneau‐Tsodikova, O. Tsodikov, H. Ngo, 2018, Journal of medicinal chemistry.

Porphyromonas gingivalis: where do we stand in our battle against this oral pathogen?

S. Garneau‐Tsodikova, O. Gonzalez, Kaitlind C Howard, 2021, RSC medicinal chemistry.

Novel fluconazole derivatives with promising antifungal activity.

S. Garneau‐Tsodikova, H. Ngo, Nishad Thamban Chandrika, 2017, Bioorganic & medicinal chemistry.

Second Generation of Zafirlukast Derivatives with Improved Activity against the Oral Pathogen Porphyromonas gingivalis.

S. Garneau‐Tsodikova, Kaitlind C Howard, O. A. Gonzalez, 2020, ACS medicinal chemistry letters.

Selective Inhibition of the Periodontal Pathogen Porphyromonas gingivalis by Third-Generation Zafirlukast Derivatives.

S. Garneau‐Tsodikova, Kaitlind C Howard, 2022, Journal of medicinal chemistry.

Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic

J. Zwicker, S. Garneau‐Tsodikova, O. Tsodikov, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.